A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
adopted by voice vote
Email me when SR 201 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SR 201. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Adopted
Summary
The Senate passed a resolution encouraging state policymakers to examine, design, and adopt economic policies that would attract biopharma companies to Kentucky. It highlights the potential for high‑paying jobs and urges incentives such as tax credits, grants, and dedicated funding pools. The measure is symbolic, aiming to keep talent and research in the state.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SR 201
3 free questions a day, no accountHistory
- adopted by voice vote
- to Senate Floor
- to Committee on Committees (S)
- introduced in Senate
Sponsors
- Shelley Frommeyer (R) · sponsor
- R. Stivers
- S. Funke Frommeyer
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SR 201 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SR 201 freeOr ask your AI assistant about SR 201 directly:
Add to Claude, ChatGPT or Cursor